DELIC HOLDINGS CORP - DELCF STOCK NEWS

Delic Holdings Corp announced its subsidiary, Delic Labs, has received a Health Canada 56 Research Exemption. This exemption allows research on various compounds including psilocybin mushrooms, MDMA, LSD, and DMT. Delic Labs aims to advance its research efforts and intends to secure a Dealer's License for further commercialization of psilocybin and its IP. This positions Delic Labs as a leader in psychedelic safety testing and quality control standards as the industry evolves.

Delic Holdings Corp (DELC, DELCF) announced the recent opening of its Ketamine Wellness Centers (KWC) in Salt Lake City and Reno, expanding its operational clinics to 13. The Salt Lake City clinic opened on January 10, 2022, while the Reno clinic began operations on March 7, 2022. KWC has also begun offering the FDA-approved SPRAVATO (esketamine) for treatment-resistant depression starting April 1, 2022. A survey by The Harris Poll revealed that 65% of Americans suffering from anxiety, depression, or PTSD support the availability of psychedelics as treatment options.

Ketamine Wellness Centers (KWC), a subsidiary of Delic Holdings Corp, has received FDA approval to offer SPRAVATO^® nasal spray starting April 1, 2022. This makes KWC the largest ketamine therapy provider in the U.S., expanding its services to patients with treatment-resistant depression (TRD) and major depressive disorder (MDD). The clinics in Houston, Las Vegas, and Seattle will implement this treatment following a thorough intake and screening process to ensure patient suitability. KWC is committed to providing affordable mental health care and assisting patients with insurance navigation.

Delic Corp, a leader in psychedelic treatments, announced participation in three key investor conferences: the Scottsdale Capital Event (April 22-24), Planet MicroCap Showcase (May 4), and H.C. Wainwright Annual Global Life Sciences Conference (May 23-26). Matt Stang, Co-founder and CEO, will discuss the company's strategic outlook and growth opportunities for the remainder of the year. The events aim to connect Delic with potential financiers and showcase its commitment to enhancing its position in the health and wellness sector through innovative therapies.

Ketamine Wellness Centers (KWC), a subsidiary of Delic Holdings Corp, has opened a new clinic in Reno, Nevada, increasing the total to 13 clinics across nine states. This 2,200 square-foot facility aims to provide affordable mental health treatments for conditions like anxiety and depression. KWC Reno, which follows the company's expansion strategy, is expected to serve both local patients and those from California lacking in-state providers. CEO Kevin Nicholson emphasizes the importance of affordable mental health care during the ongoing crisis.

Delic Holdings Corp announced that Dr. Markus Roggen, President and Chief Science Officer of DELIC Labs, will present on Artificial Intelligence for Craft Cannabis Products at the Emerald Conference on February 28, 2022, at 12:45 PM PT. DELIC Labs, a federally-authorized cannabis research laboratory, focuses on extraction optimization and product development. Dr. Roggen emphasized that the quality and cost of extraction are critical for production. DELIC Labs aims to innovate within the cannabis and psilocybin industries, conducting advanced research and development.

Delic Holdings Corp (DELCF) announced its plans to double its footprint by opening 15 new ketamine clinics in the next 18 months, adding to its current 12 locations. The company reported a revenue run-rate exceeding US$9 million and is EBITDA positive. Following the acquisition of Ketamine Wellness Centers in November 2021, Delic now operates the largest chain of mental health clinics in the U.S., which is projected to generate substantial revenue growth. The company's strategy is aimed at improving accessibility and addressing the increasing demand for mental health services.

Delic Holdings Corp announced the opening of its first ketamine clinic in Utah, located in Salt Lake City, through its subsidiary, Ketamine Wellness Centers (KWC). This clinic is set to be one of the largest in the U.S., comprising seven treatment rooms and creating ten new jobs. KWC aims to address the high rates of mental health concerns in Utah by providing accessible, effective treatments for conditions like depression and PTSD. The clinic marks a strategic expansion for Delic, enhancing its network of 11 clinics across nine states and building on its commitment to affordable mental health care.